• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E2F1 通过调节同源重组修复中涉及的 RAD54L 促进膀胱癌的进展。

E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair.

机构信息

Department of Biological Sciences, Dong-A University, Busan 49315, Korea.

Department of Bioinformatics, KRIBB School of Bioscience, Korea University of Science and Technology, Daejeon 34113, Korea.

出版信息

Int J Mol Sci. 2020 Nov 27;21(23):9025. doi: 10.3390/ijms21239025.

DOI:10.3390/ijms21239025
PMID:33261027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7730422/
Abstract

DNA repair defects are important factors in cancer development. High DNA repair activity can affect cancer progression and chemoresistance. DNA double-strand breaks in cancer cells caused by anticancer agents can be restored by non-homologous end joining (NHEJ) and homologous recombination repair (HRR). Our previous study has identified E2F1 as a key gene in bladder cancer progression. In this study, DNA repair genes related to E2F1 were analyzed, and RAD54L involved in HRR was identified. In gene expression analysis of bladder cancer patients, the survival of patients with high RAD54L expression was shorter with cancer progression than in patients with low RAD54L expression. This study also revealed that E2F1 directly binds to the promoter region of RAD54L and regulates the transcription of RAD54L related to the HRR pathway. This study also confirmed that DNA breaks are repaired by RAD54L induced by E2F1 in bladder cancer cells treated with MMC. In summary, RAD54L was identified as a new target directly regulated by E2F1. Our results suggest that, E2F1 and RAD54L could be used as diagnostic markers for bladder cancer progression and represent potential therapeutic targets.

摘要

DNA 修复缺陷是癌症发展的重要因素。高 DNA 修复活性会影响癌症的进展和化疗耐药性。抗癌药物引起的癌细胞中的 DNA 双链断裂可以通过非同源末端连接 (NHEJ) 和同源重组修复 (HRR) 来修复。我们之前的研究已经确定 E2F1 是膀胱癌进展的关键基因。在这项研究中,分析了与 E2F1 相关的 DNA 修复基因,并确定了参与 HRR 的 RAD54L。在膀胱癌患者的基因表达分析中,RAD54L 高表达的患者比 RAD54L 低表达的患者在癌症进展时的生存时间更短。本研究还表明,E2F1 直接结合 RAD54L 的启动子区域,并调节与 HRR 途径相关的 RAD54L 的转录。本研究还证实,在 MMC 处理的膀胱癌细胞中,E2F1 诱导的 RAD54L 修复了 DNA 断裂。总之,RAD54L 被确定为 E2F1 直接调控的新靶标。我们的研究结果表明,E2F1 和 RAD54L 可作为膀胱癌进展的诊断标志物,并代表潜在的治疗靶点。

相似文献

1
E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair.E2F1 通过调节同源重组修复中涉及的 RAD54L 促进膀胱癌的进展。
Int J Mol Sci. 2020 Nov 27;21(23):9025. doi: 10.3390/ijms21239025.
2
Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.通过抑制 APLF 利用经典 NHEJ 重编 E2F1 促进膀胱癌侵袭性。
J Exp Clin Cancer Res. 2019 Jul 8;38(1):292. doi: 10.1186/s13046-019-1286-9.
3
RAD54L promotes progression of hepatocellular carcinoma via the homologous recombination repair pathway.RAD54L 通过同源重组修复途径促进肝细胞癌的进展。
Funct Integr Genomics. 2023 Apr 18;23(2):128. doi: 10.1007/s10142-023-01060-w.
4
Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence.Rad54L 通过调控细胞周期和细胞衰老促进膀胱癌进展。
Med Oncol. 2022 Sep 7;39(12):185. doi: 10.1007/s12032-022-01751-7.
5
Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.E2F1 调控的 EZH2 和 SUZ12 激活预测膀胱癌的疾病进展和侵袭特征。
Clin Cancer Res. 2015 Dec 1;21(23):5391-403. doi: 10.1158/1078-0432.CCR-14-2680. Epub 2015 Aug 12.
6
RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.RB定位于DNA双链断裂处,并通过招募BRG1促进DNA末端切除和同源重组。
Genes Dev. 2016 Nov 15;30(22):2500-2512. doi: 10.1101/gad.288282.116.
7
The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.长链非编码 RNA FOXD2-AS1 通过与 Akt 和 E2F1 的正反馈环路促进膀胱癌的进展和复发。
Cell Death Dis. 2018 Feb 14;9(2):233. doi: 10.1038/s41419-018-0275-9.
8
Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities.具有不同基因组稳定性特征的乳头状和肌层浸润性膀胱肿瘤具有不同的DNA修复保真度和KU DNA结合活性。
Genes Chromosomes Cancer. 2009 Apr;48(4):310-21. doi: 10.1002/gcc.20641.
9
Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer.脂肪酸合酶、Her2/neu 和 E2F1 作为非肌肉浸润性膀胱癌进展的预后标志物。
Ann Diagn Pathol. 2019 Apr;39:42-52. doi: 10.1016/j.anndiagpath.2019.01.002. Epub 2019 Jan 17.
10
RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression.RNF126通过调控E2F1介导的BRCA1表达促进同源重组。
Oncogene. 2016 Mar 17;35(11):1363-72. doi: 10.1038/onc.2015.198. Epub 2015 Aug 3.

引用本文的文献

1
Therapeutic implications and comprehensive insights into cellular senescence and aging in the tumor microenvironment of sarcoma.肉瘤肿瘤微环境中细胞衰老与老化的治疗意义及综合见解
Discov Oncol. 2025 Jan 15;16(1):50. doi: 10.1007/s12672-025-01757-3.
2
Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification.非肌层浸润性膀胱癌进展的分子生物标志物——超越传统风险分层
Nat Rev Urol. 2025 Feb;22(2):75-91. doi: 10.1038/s41585-024-00914-7. Epub 2024 Aug 2.
3
Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma.

本文引用的文献

1
Fanconi Anemia Pathway Activation by FOXM1 Is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance.FOXM1介导的范可尼贫血通路激活对膀胱癌复发和抗癌药物耐药性至关重要。
Cancers (Basel). 2020 May 30;12(6):1417. doi: 10.3390/cancers12061417.
2
E2F1 facilitates DNA break repair by localizing to break sites and enhancing the expression of homologous recombination factors.E2F1通过定位于断裂位点并增强同源重组因子的表达来促进DNA断裂修复。
Exp Mol Med. 2019 Sep 18;51(9):1-12. doi: 10.1038/s12276-019-0307-2.
3
DNA repair in cancer initiation, progression, and therapy-a double-edged sword.
透明细胞肾细胞癌中与G2M检查点相关的基因模型及与免疫治疗反应相关的亚型的特征分析
Heliyon. 2024 Apr 5;10(7):e29289. doi: 10.1016/j.heliyon.2024.e29289. eCollection 2024 Apr 15.
4
Overexpression of RAD54L attenuates osteoarthritis by suppressing the HIF-1α/VEGF signaling pathway: Bioinformatics analysis and experimental validation.RAD54L 过表达通过抑制 HIF-1α/VEGF 信号通路减轻骨关节炎:生物信息学分析和实验验证。
PLoS One. 2024 Apr 9;19(4):e0298575. doi: 10.1371/journal.pone.0298575. eCollection 2024.
5
RNA mC modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer.mC 修饰的 RNA 通过依赖于 YBX1 相分离的方式上调 E2F1 的表达,并促进卵巢癌的肿瘤进展。
Exp Mol Med. 2024 Mar;56(3):600-615. doi: 10.1038/s12276-024-01184-4. Epub 2024 Mar 1.
6
PRPF19 functions in DNA damage repair and gemcitabine sensitivity via regulating DDB1 in bladder cancer cells.PRPF19通过调控膀胱癌细胞中的DDB1在DNA损伤修复和吉西他滨敏感性中发挥作用。
Cytotechnology. 2024 Feb;76(1):85-96. doi: 10.1007/s10616-023-00599-7. Epub 2023 Oct 5.
7
Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.人类多能干细胞中的 20q11.21 增益:癌症研究的新视角。
Stem Cell Reports. 2024 Jan 9;19(1):11-27. doi: 10.1016/j.stemcr.2023.11.013. Epub 2023 Dec 28.
8
Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression E2F transcription factor 1/G protein subunit alpha Z axis.长链非编码RNA CDKN2B-AS1通过E2F转录因子1/G蛋白亚基αZ轴促进肝细胞癌进展。
World J Gastrointest Oncol. 2023 Nov 15;15(11):1974-1987. doi: 10.4251/wjgo.v15.i11.1974.
9
miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A.微小RNA-3200通过增强Rab7A促进肝癌细胞生长。
Noncoding RNA Res. 2023 Oct 10;8(4):675-685. doi: 10.1016/j.ncrna.2023.10.005. eCollection 2023 Dec.
10
Pan-Cancer Analysis of Oncogenic Role of RAD54L and Experimental Validation in Hepatocellular Carcinoma.RAD54L致癌作用的泛癌分析及在肝细胞癌中的实验验证
J Inflamm Res. 2023 Sep 11;16:3997-4017. doi: 10.2147/JIR.S426558. eCollection 2023.
癌症发生、进展和治疗中的 DNA 修复——一把双刃剑。
J Appl Genet. 2019 Nov;60(3-4):329-334. doi: 10.1007/s13353-019-00516-9. Epub 2019 Aug 30.
4
The Rad51 paralogs facilitate a novel DNA strand specific damage tolerance pathway.Rad51 同源物促进了一种新的 DNA 链特异性损伤耐受途径。
Nat Commun. 2019 Aug 5;10(1):3515. doi: 10.1038/s41467-019-11374-8.
5
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment.癌症干细胞在耐药性中的作用及其在癌症治疗中的治疗意义
Stem Cells Int. 2018 Feb 28;2018:5416923. doi: 10.1155/2018/5416923. eCollection 2018.
7
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1.FOXM1 通过激活 ABCG2 导致膀胱癌耐药。
BMB Rep. 2018 Feb;51(2):98-103. doi: 10.5483/bmbrep.2018.51.2.222.
8
The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.核心非同源末端连接因子在致癌作用和癌症中的作用
Cancers (Basel). 2017 Jul 6;9(7):81. doi: 10.3390/cancers9070081.
9
DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.来自抗癌药物的DNA加合物作为精准医学的候选预测标志物。
Chem Res Toxicol. 2017 Jan 17;30(1):388-409. doi: 10.1021/acs.chemrestox.6b00380. Epub 2017 Jan 3.
10
Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.E2F1 调控的 EZH2 和 SUZ12 激活预测膀胱癌的疾病进展和侵袭特征。
Clin Cancer Res. 2015 Dec 1;21(23):5391-403. doi: 10.1158/1078-0432.CCR-14-2680. Epub 2015 Aug 12.